These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7116758)

  • 41. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experience with labetalol in essential hypertension.
    Tuomilehto J; Nissinen A; Elo J
    Curr Med Res Opin; 1980; 6(6):407-15. PubMed ID: 7363641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous labetalol for the treatment of hypertension after carotid endarterectomy.
    Goldberg ME; Seltzer JL; Azad SS; Smullens SN; Marr AT; Larijani GE
    J Cardiothorac Anesth; 1989 Aug; 3(4):411-7. PubMed ID: 2577702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral labetalol versus oral clonidine in the emergency treatment of severe hypertension.
    Atkin SH; Jaker MA; Beaty P; Quadrel MA; Cuffie C; Soto-Greene ML
    Am J Med Sci; 1992 Jan; 303(1):9-15. PubMed ID: 1728876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Labetalol, a combined alpha- and beta-blocker, in hypertension of pregnancy.
    Lunell NO; Fredholm B; Hjemdahl P; Lewander R; Nisell H; Nylund L; Persson B; Sarby B; Wager J
    Acta Med Scand Suppl; 1982; 665():143-7. PubMed ID: 6961761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Br J Clin Pharmacol; 1981 Sep; 12(3):349-53. PubMed ID: 7295465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.
    Frick MH; Pörsti P
    Br Med J; 1976 May; 1(6017):1046-8. PubMed ID: 773498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poor hypotensive response and tachyphylaxis following intravenous labetalol.
    Anderson CC; Gabriel R
    Curr Med Res Opin; 1978; 5(5):424-6. PubMed ID: 350494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
    Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
    Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Labetalol in the treatment of hypertension in elderly and younger patients.
    Abernethy DR; Bartos P; Plachetka JR
    J Clin Pharmacol; 1987 Nov; 27(11):902-6. PubMed ID: 2892866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metoclopramide enhances labetalol-induced antihypertensive effect during handgrip in hypertensive patients.
    Blanco M; Gomez J; Negrín C; Blanco G; Rodriguez M; Torres M; Vásquez M; Alcalá I; Vargas R; Velasco M
    Am J Ther; 1998 Jul; 5(4):221-4. PubMed ID: 10099062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral labetalol in hypertensive urgencies.
    Zell-Kanter M; Leikin JB
    Am J Emerg Med; 1991 Mar; 9(2):136-8. PubMed ID: 1994940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of hypertension following endotracheal intubation. A study comparing the efficacy of labetalol, practolol and placebo.
    Maharaj RJ; Thompson M; Brock-Utne JG; Williamson R; Downing JW
    S Afr Med J; 1983 Apr; 63(18):691-4. PubMed ID: 6342168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.